HMGCS2 and clear cell renal carcinoma: Previous studies have also indicated that low expression of HMGCS2 is an adverse prognostic factor in hepatocellular carcinoma (HCC)25, 57–59, but there have been no specific reports on renal clear cell carcinoma to date.